Skip to content

PursueCare RESET 2.0.2

by Harvest Bio LLC 2 variants

PursueCare RESET 2.0.2 is a mental health/function therapeutic software (FDA Class II; FDA product code PWE, Computerized Behavioral Therapy Device For Substance Use Disorders) made by Harvest Bio LLC, granted FDA De Novo DEN160018 on 14 Sep 2017 and listed in FDA GUDID since 28 Apr 2025 (UDI-DI 00850074433002), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

De Novo DEN160018

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00850074433002 UDI-DI Date28 Apr 2025ListedStatusListed GUDID: in commercial distribution
United StatesFDA De NovoDENG from GUDID De Novo granted · Direct NumberDEN160018 Date14 Sep 2017DecidedStatusActive

Official records

From the FDA record

Device description
RESET Mobile Application runs on iOS and is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA De Novo DEN160018 decided 14 Sep 2017 Active
  • FDA GUDID UDI-DI 00850074433002 listed 28 Apr 2025 Listed

Timeline

2 dated events

  1. Granted FDA De Novo DEN160018
  2. Listed FDA GUDID 00850074433002

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

GUDID

Trade name
PursueCare RESET
Generic name
Mental health/function therapeutic software, screen-viewed
Model / reference
2.0.2
Primary DI / UDI-DI
00850074433002
De Novo Number
FDA product code
PWE
GMDN term
Mental health/function therapeutic software, screen-viewed
Device class
Class II
Regulation number
882.5801
GUDID distribution status
In Commercial Distribution

Other devices from Harvest Bio LLC

Properties

  • Prescription use
  • Lot / batch number
Other properties (13, all answered No)